SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-24-131959
Filing Date
2024-05-06
Accepted
2024-05-06 16:24:35
Documents
2

Document Format Files

Seq Description Document Type Size
1 S-3/A d42232ds3a.htm S-3/A 70081
2 EX-23.1 d42232dex231.htm EX-23.1 1521
  Complete submission text file 0001193125-24-131959.txt   72708
Mailing Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805
Business Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805 (302) 467-1280
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-277123 | Film No.: 24917906
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)